Genmab (NASDAQ:GMAB) reported its Q1 earnings results on Wednesday, May 10, 2023 at 11:00 AM.

Here's what investors need to know about the announcement.

Earnings

Genmab missed estimated earnings by 92.31%, reporting an EPS of $0.05 versus an estimate of $0.65.

Revenue was up $91.68 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $3.06 which was followed by a 1.58% drop in the share price the next day.

Here's a look at Genmab's past performance:

To track all earnings releases for Genmab visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.